Method for inducing oligodendrocyte precursor cells from oct4-induced human somatic cells through direct reprogramming

a technology of oligodendrocyte precursor cells and human somatic cells, which is applied in the field of inducing oligodendrocyte precursor cells, can solve the problems of low differentiation ability, no fundamental therapy, and ineffective nscs

Inactive Publication Date: 2018-06-07
STEMLAB
View PDF1 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0015]The present invention also provides a method of differentiating OPCs into oligodendrocytes, the method including: culturing the OPCs prepared by the above-described method in a medium containing a ROCK inhibitor, a calcium channel agonist and a leukemia inhibitory factor (LIF).

Problems solved by technology

However, there is no fundamental therapy, except treatment with medications for reducing symptoms.
However, NSCs are not effective because they have a considerably low ability to differentiate into oligodendrocytes, and are limited in number of cells because they should be obtained from a patient's own cerebral tissue.
Embryonic stem cells also have disadvantages to be overcome for clinical use.
First, there is an ethical issue because it is necessary to destroy a fertilized embryo to obtain embryonic stem cells, and when cells differentiated from the embryonic stem cells are transplanted into a patient, immune rejection occurs.
However, because of still insufficient results of the study on human somatic cells, difficulty in defining a dedifferentiation-inducing mechanism, and a risk of forming teratoma, it is difficult to apply iPS cells to clinical trials.
However, there is no still report in which human somatic cells are used.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for inducing oligodendrocyte precursor cells from oct4-induced human somatic cells through direct reprogramming
  • Method for inducing oligodendrocyte precursor cells from oct4-induced human somatic cells through direct reprogramming
  • Method for inducing oligodendrocyte precursor cells from oct4-induced human somatic cells through direct reprogramming

Examples

Experimental program
Comparison scheme
Effect test

example 1

Selection of Low Molecular Weight Substance and Establishment of Induction Conditions

1-1: Selection of Low Molecular Weight Substance Using Sox10 Reporter System

[0072]The inventors have established conditions capable of inducing neural stem cells from mouse cells only with a low molecular weight substance without gene introduction (KR 10-1357402). Accordingly, to establish new conditions capable of inducing human somatic cells into OPCs on the basis of the low molecular weight substance that had been established in the previous study, a low molecular weight substance was selected using a Sox10 reporter system (Sox10::eGFP), which is a gene known to be important in development of oligodendrocytes (FIG. 1).

[0073]When Oct4 gene-introduced cells were cultured in a reprogramming medium (RM: DMEM with high Glucose+5% knock out serum replacement (KSR)+1% penicillin / streptomycin+1% non-essential amino acids+20 ng / ml basic FGF (bFGF)+20 ng / ml human recombinant platelet derived growth factor ...

example 2

Induction and Confirmation of OPCs from Human Somatic Cells

[0081]Since the Sox10::eGFP fibroblasts used as the reporter cell line of Example 1-1 are cells obtained through differentiation from embryonic stem cells (ES cells), other stem cells, excluding fibroblasts, may not be completely excluded, and thus it may not be seen as direct reprogramming from somatic cells. In addition, since a KSR-containing medium was used in the establishment of neural stem cells after Oct4 was overexpressed in human somatic cells by Shengding and Mickie Bhatia research teams in the United States, in this Example, to induce direct reprogramming from human somatic cells which are not derived from embryos without via neural stem cells, which are upper stem cells of the OPCs, a KSR-containing reprogramming medium (RM) was not used (FIG. 7).

[0082]That is, as a result of introducing an Oct4 gene into BJ cells, subculturing in a Matrigel-coated dish, and culturing for 4 days under induction conditions (IM) f...

example 3

Differentiation of OPCs into Oligodendrocytes

3-1: Differentiation into Oligodendrocytes

[0085]To confirm an ability to differentiate OPCs induced in Example 2 into oligodendrocytes, a growth factor was removed from a conventional medium, and the medium was replaced with a differentiation medium (DMEM with high glucose+1× N2+1× B27 (without vitamin A)+1% penicillin / streptomycin+1% non-essential amino acids+50 μg / ml ascorbic acid+40 ng / ml T3 (triiodo-1-thyronine)+0.5 μM thiazovivin+10 μM forskolin+10 ng / ml human leukemia inhibitor factor (LIF)).

[0086]As a result, a typical branch-type morphology of the oligodendrocyte was shown, and real-time PCR showed that MBP and MAG expression increased (FIG. 12).

[0087]In addition, as a result of co-culturing with neurons obtained from the hippocampus of a rat to confirm in vitro myelination by differentiated oligodendrocytes, it was confirmed that the neurons were myelinated by the differentiated oligodendrocytes (FIG. 13).

3-2: Confirmation of In ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
molecular weightaaaaaaaaaa
morphologyaaaaaaaaaa
concentrationaaaaaaaaaa
Login to view more

Abstract

Provided is a method of inducing oligodendrocyte precursor cells (OPCS) through direct reprogramming from human somatic cells into which a nucleic acid molecule encoding an Oct4 protein or Oct4 protein-treated human somatic cells. The method of inducing OPCs by treating Oct4-overexpressing human somatic cells with a low molecular weight substance may establish OPCs with high efficiency in a short period of time through direct reprogramming without via neural stem cells, and thus the OPCs are useful as a cell therapeutic agent for an intractable demyelinating disease.

Description

TECHNICAL FIELD[0001]The present invention relates to a method of inducing oligodendrocyte precursor cells (OPCs) through direct reprogramming from human somatic cells into which a nucleic acid molecule encoding an Oct4 protein has been introduced or Oct4 protein-treated human somatic cells.BACKGROUND ART[0002]Due to the progression of an aging society, personalized cell therapeutic agents for healthier aging and a healthy life without disease are medications essential for improving the quality of life. Multiple sclerosis known as a disease of the central nervous system is a demyelinating disease whose cause is unknown, and in severe cases, is accompanied by sensory and motor impairment. However, there is no fundamental therapy, except treatment with medications for reducing symptoms. Accordingly, transplantation of OPCs (OPC) that can differentiate into oligodendrocytes enabling the generation of myelin sheaths has attracted attention as a main therapeutic method, and research to o...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(United States)
IPC IPC(8): C12N5/079A61K35/32
CPCC12N5/0622A61K35/32C12N2506/00C12N2501/603C12N2501/15C12N2501/727C12N2501/73C12N2501/065C12N2501/41C12N2501/999C12N2501/2306C12N5/0018C12N2506/092C12N2506/1307C12N2501/00C12N2500/00C12N2501/115C12N2501/135C12N2501/235C12N15/85
Inventor YOU, SEUNG KWONYUN, WON-JINPARK, MIN JIPARK, JI-YONG
Owner STEMLAB
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap